- The U.S. Federal Trade Commission is suing Hims & Hers alleging the telehealth platform shared users' health data with online advertisers despite promising privacy and engaged in deceptive billing and cancellation practices, an FTC spokesperson said.
- Users' sensitive health information was shared with online advertising companies including Meta Platforms and Snap, via their interactions with Hims' website and through tracking technologies, the FTC plans to allege in the lawsuit.
- Hims & Hers also starts charging users for prescriptions before they have had a chance to meet with healthcare providers, the spokesperson said.
- Most customers do not receive a consultation with a provider, and instead are charged for prescriptions soon after filling out an intake form, according to the agency.
- The FTC also alleges that Hims & Hers makes it difficult to cancel subscriptions.
- Hims and Hers denied wrongdoing in a post on X, calling the lawsuit unsupported after a nearly three-year FTC investigation.
- The investigation by the FTC dates back to October 2023.
- In April 2026, the FTC began settlement discussions with Hims & Hers regarding the findings of its probe.
- The FTC lawsuit was filed against Hims & Hers in May 2026.
- The FTC, joined by Los Angeles County and Utah, alleged Hims and Hers shared users' sensitive health information with online advertising platforms through tracking technologies without proper consent.
- The agency said the company's practices were inconsistent with promises it made to protect users' health data.
- Hims & Hers Health faces risks including a permanent injunction, monetary penalties, and increased regulatory scrutiny over its data-sharing and subscription practices.
- Allegations that Hims & Hers shared sensitive health data with advertisers could damage consumer trust and lead to loss of customers or operational changes.
- Hims & Hers Health denies the charges, claiming the lawsuit ignores key information and states it will vigorously defend itself against the claims.
The U.S. Federal Trade Commission (FTC) has filed a lawsuit against Hims & Hers, alleging the telehealth platform shared sensitive user health data with Meta and Snap without proper consent. The lawsuit, which also includes claims from Los Angeles County and Utah, accuses the company of violating consumer protection laws.1
According to the FTC, Hims & Hers engaged in deceptive billing practices by charging customers for prescriptions before they had consultations with healthcare providers. “Most customers do not receive a consultation with a provider,” the FTC stated, highlighting that many are billed immediately after completing an intake form.4
The agency further alleges that Hims & Hers made it difficult for users to cancel subscriptions, undermining their promises to protect user health data. “The company’s practices were inconsistent with promises it made to protect users' health data,” the FTC noted.11
In response, Hims & Hers has denied the allegations, claiming the lawsuit is unsupported and disregards substantial evidence from a nearly three-year investigation. The company stated it will vigorously defend itself against the claims, which could lead to monetary penalties and increased regulatory scrutiny.6
The investigation by the FTC began in October 2023, with findings shared with Hims & Hers in April 2023, leading to settlement discussions. The lawsuit could significantly impact consumer trust and the company's operations.8
“The FTC claims Hims & Hers shared sensitive health information with advertisers without consent, violating consumer protection laws. Additionally, the company is accused of charging customers for prescriptions before consultations, raising concerns about user trust and potential operational changes.”
CNBC
Seeking Alpha
